Page 1
His ADHD symptoms can be disruptive, but there’s a great kid in there.
Now there’s a new way to help him out…
New for the treatment of ADHD

Spread (pages 2 and 3):
Introducing once-daily Intuniv
A new way to reach the kid within
Intuniv demonstrated significant improvement in ADHD symptoms, which can be disruptive.
New for the treatment of ADHD

To see all of the ads from this campaign, click here

Brand name: intuniv
Generic name/category: Guanfacine, Antihypertensive agents, Guanidines, Alpha-adrenergic agonists
Company: Shire
Country/Market: USA, North America
Indication(s)/use: attention-deficit hyperactivity disorder (ADHD)
Target: Healthcare Professionals (HCP)
Tagline: A new way to reach the kid within
Medium: Print ad
Size/duration: Three-page spread
Publication/Aired: Contemporary Pediatrics – November 2009

To see all of this brand’s ads on AdPharm, click here

Click here to see the details and full-size version of this ad on AdPharm

AdPharm is the largest online pharmaceutical advertising gallery. It is subscription-based with various subscriptions plans available here.

Click here to see it on AdPharm

AdPharm is the largest online pharmaceutical advertising gallery. It is subscription-based with various subscriptions plans available here.

Click on image to view ad details and full-size version on AdPharm

To see all of this brand’s ads on AdPharm, click here

Click on image to view ad details and full-size version on AdPharm

Click on thumbnail to view the full-size ad on AdPharm

In Pulmonary Arterial Hypertension (PAH) NYHA class III or IV
Give your PAH patients a second wind

New Ventavis 20 mcg/mL
Shorter treatment times. Higher concentration.

The only inhaled PAH therapy to demonstrate a spectrum of PAH efficacy.

Smart technology from the I-neb AAD by Philips Respironics

Iloprost is a drug used to treat pulmonary arterial hypertension (PAH), scleroderma, Raynaud’s phenomenon and ischaemia. It was developed by the pharmaceutical company Schering AG and is marketed by Bayer Schering Pharma AG in Europe and Actelion Pharmaceuticals in the USA.

More on Wikipedia

Brand name: Ventavis
Generic name/category: Iloprost, Prostaglandins, Alkynes
Company: Actelion
Country/Market: USA, North America
Indication(s)/use: Pulmonary Arterial Hypertension (PAH) NYHA class III or IV
Target: Healthcare Professionals (HCP)
Tagline: A spectrum of inhaled PAH efficacy
Medium: Print ad
Size/duration: three-page spread
Publication/Aired: Chest – September 2009

To see all of this brand’s ads on AdPharm, click here

Click on thumbnail to view the full-size ad on AdPharm

Introducing Simponi.
The first monthly SC anti TNF a…

… all in one

-Proven efficacy in RA, As and PsA
-SmartJect autoinjector – designed to be patient-friendly
-Low injection volume (0.5 mL)
-Human lgG1k monoclonal antibody
-Patient support through the BioAdvantage Network

Monthly Simponi

The Simponi SmartJect autoinjector. Designed to be arthritis-patient-friendly.

Brand name: Simponi
Generic name/category: Golimumab, Monoclonal antibodies, TNF-alpha inhibitors
Company: Schering-Plough
Country/Market: Canada, North America
Indication(s)/use: Rheumatoid Arthritis (RA), Psoriatic Arthritis (PsA) and Ankylosing Spondilitis (AS)
Target: Healthcare Professionals (HCP)
Tagline: all in one
Medium: Print ad
Size/duration: three-page spread
Publication/Aired: NEJM – September 24, 2009

To see all of this brand’s ads on AdPharm, click here

Click on thumbnail to view the full-size ad on AdPharm

Help deliver response in chronic Phase Ph+ CML After Gleevec

Brand name: Tasigna
Generic name/category: nilotinib, Tyrosine kinase inhibitors, Antineoplastic drugs
Company: Novartis Oncology
Country/Market: USA, North America
Indication(s)/use: chronic phase and accelerated phase Philadelphia chromosome-positive (Ph+) chronic myelogenous leukemia (CML)
Target: Healthcare Professionals (HCP)
Tagline: Help deliver response
Medium: Print ad
Size/duration: three-page spread
Publication/Aired: Blood – August 27, 2009